Srdjan Markovic

9PUBLICATIONS
21CO-AUTHORS
AutoimmunityCancer geneticsPharmacogenomicsCardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 27, 2026
Adalimumab Safety in Inflammatory Bowel Disease: A Clinical Cohort Study with Time-to-Event Analysis and FAERS Signal Assessment.

|Aug 27, 2026
MADCAM1 Gene Variants as Potential Pharmacogenomics Markers for Vedolizumab Response in Crohn's Disease Bio-Naïve Patients.

|Jul 28, 2026
Unlocking the Potential of Population Pharmacokinetic Models of Adalimumab in Patients with Crohn's Disease.

|Jun 26, 2026
Prioritizing Antidiabetic Drugs for Inflammatory Bowel Disease Through Inverse Signal Detection: A FAERS Pharmacovigilance Study.

|Mar 28, 2026
Arterial Thrombosis in Severe Ulcerative Colitis: A Case-Based Narrative Review of Current Evidence.

Djordje Kralj, Mladen Maksic, Tamara Knezevic Ivanovski

|Jan 28, 2026
Pharmacogenomic Pathways Underlying Variable Vedolizumab Response in Crohn's Disease Patients: A Rare-Variant Analysis.

Biljana Stankovic, Mihajlo Stasuk, Vladimir Gasic

Pageof 2

Frequent Collaborators

4 joint publications

Đorđe Kralj

4 joint publications

Petar Svorcan

4 joint publications

Katarina Vučićević

3 joint publications

Branislava Miljković